Obesity Surgery

, Volume 26, Issue 8, pp 1659–1696 | Cite as

Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)

  • Maurizio De LucaEmail author
  • Luigi Angrisani
  • Jacques Himpens
  • Luca Busetto
  • Nicola Scopinaro
  • Rudolf Weiner
  • Alberto Sartori
  • Christine Stier
  • Muffazal Lakdawala
  • Aparna G. Bhasker
  • Henry Buchwald
  • John Dixon
  • Sonja Chiappetta
  • Hans-Christian Kolberg
  • Gema Frühbeck
  • David B. Sarwer
  • Michel Suter
  • Emanuele Soricelli
  • Mattias Blüher
  • Ramon Vilallonga
  • Arya Sharma
  • Scott Shikora
List of contents
  • Final Recommendations

  • Preamble

  • Chapter 1: Surgery for Obesity and Weight Related Diseases

  • Chapter 2: The limitations of BMI and antrophometric measures, when applied to individuals as indications for surgery

  • Chapter 3: Specific considerations and indications for intervention in presence of weight-related diseases
    • Sub-chapter 3.1: Diabetes and metabolic syndrome

    • Sub-chapter 3.2: Cardiovascular diseases

    • Sub-chapter 3.3: Pulmonary diseases

    • Sub-chapter 3.4: Osteoarthritis

    • Sub-chapter 3.5: Gastroesophageal reflux diseases

    • Sub-chapter 3.6: Hepatobiliary diseases

    • Sub-chapter 3.7: Mental health

    • Sub-chapter 3.8: Endoscrinopathies and fertility

    • Sub-chapter 3.9: Cancer and organ transplantation

    • Sub-chapter 3.10: Pseudotumor cerebri

    • Sub-chapter 3.11: Chronic Inflammation

    • Sub-chapter 3.12: Renal alterations

    • Sub-chapter 3.13: Functional status

  • Chapter 4: General considerations for indications of metabolic surgery
    • Sub-chapter 4.1: Quality of life

    • Sub-chapter 4.2: Adolescents

    • Sub-chapt...


Compliance with Ethical Standards

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Buchwald H, Varco RL. Editors, metabolic surgery. New York: Grune and Stratton; 1978.Google Scholar
  2. 2.
    Buchwald H, Varco RL, Matts JP, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med. 1990;323(14):946–55.PubMedCrossRefGoogle Scholar
  3. 3.
    Kremen AJ, Linner LH, Nelson CH. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg. 1954;140(3):439–48.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Buchwald H. The evolution of metabolic/bariatric surgery. Obes Surg. 2014;24(8):1126–35.PubMedCrossRefGoogle Scholar
  5. 5.
    Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care. 2009;32(12):2297–9.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    NIH conference. Gastrointestinal surgery for severe obesity. consensus development conference panel. Ann Intern Med. 1991;115(12):956–61.CrossRefGoogle Scholar
  7. 7.
    Sjöström L, Lindroos AK, Peltonen M, et al. Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.Google Scholar
  8. 8.
    Sjöström L, Gummesson A, Sjöström CD, et al. Swedish Obese Subjects Study. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10(7):653–62.PubMedCrossRefGoogle Scholar
  9. 9.
    Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.PubMedCrossRefGoogle Scholar
  10. 10.
    Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Dixon JB, Zimmet P, Alberti KG, et al. International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;28(6):628–42.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.PubMedCrossRefGoogle Scholar
  13. 13.
    Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA. 2013;309(21):2240–9.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery. a systemic review and meta-analysis. JAMA. 2004;292(14):1724–37.PubMedCrossRefGoogle Scholar
  15. 15.
    Christou NV, Lieberman M, Sampalis F, et al. Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Relat Dis. 2008;4(6):691–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416–23.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Busetto L, Mirabelli D, Petroni ML, et al. Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis. 2007;3(5):496–502.PubMedCrossRefGoogle Scholar
  18. 18.
    Aguiar IC, Freitas Jr WR, Santos IR, et al. Obstructive sleep apnea and pulmonary function in patients with severe obesity before and after bariatric surgery: a randomized clinical trial. Multidiscip Respir Med. 2014;9(1):43.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122(6):535–42.PubMedCrossRefGoogle Scholar
  20. 20.
    Poirier P, Cornier MA, Mazzone T, et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123(15):1683–701.PubMedCrossRefGoogle Scholar
  21. 21.
    Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56. e5.PubMedCrossRefGoogle Scholar
  22. 22.
    Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.PubMedCrossRefGoogle Scholar
  23. 23.
    Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1–452.Google Scholar
  24. 24.
    Wang J, Thornton JC, Russell M, et al. Asians have lower body mass index (BMI) but higher percent body fat than do Whites: comparisons of anthropometric measurements. Am J Clin Nutr. 1994;60(1):23–8.PubMedGoogle Scholar
  25. 25.
    Yajnik CS. Obesity epidemic in India: intrauterine origins? Proc Nutr Soc. 2004;63(3):387–96.PubMedCrossRefGoogle Scholar
  26. 26.
    Ko GT, Tang JS. Waist circumference and BMI cut-off based on 10-year cardiovascular risk: evidence for “central pre-obesity”. Obesity (Silver Spring). 2007;15(11):2832–9.CrossRefGoogle Scholar
  27. 27.
    Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962;14:353–62.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291(3):335–42.PubMedCrossRefGoogle Scholar
  29. 29.
    Summary of revisions for the 2009 clinical practice recommendations. Diabetes Care. 2009;32 Suppl 1:S3–5.Google Scholar
  30. 30.
    Dixon JB, Zimmet P, Alberti KG. Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Surg Obes Relat Dis. 2011;7(4):433–47.PubMedCrossRefGoogle Scholar
  31. 31.
    Lakdawala M, Bhasker A. Asian Consensus Meeting on Metabolic Surgery (ACMOMS). Report: Asian consensus meeting on metabolic surgery. Recommendations for the use of bariatric and gastrointestinal metabolic surgery for treatment of obesity and type II diabetes mellitus in the Asian population: August 9th and 10th, 2008, Trivandrum, India. Obes Surg. 2010;20(7):929–36.PubMedCrossRefGoogle Scholar
  32. 32.
    Müller MJ, Lagerpusch M, Enderle J, et al. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev. 2012;13 Suppl 2:6–13.PubMedCrossRefGoogle Scholar
  33. 33.
    Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology. 2003;144(12):5159–65.PubMedCrossRefGoogle Scholar
  34. 34.
    Kragelund C, Omland T. A farewell to body-mass index? Lancet. 2005;366(9497):1589–91.PubMedCrossRefGoogle Scholar
  35. 35.
    Okorodudu DO, Jumean MF, Montori VM, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond). 2010;34(5):791–9.CrossRefGoogle Scholar
  36. 36.
    Expert Consultation WHO. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63.CrossRefGoogle Scholar
  37. 37.
    Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009;33(3):289–95.CrossRefGoogle Scholar
  38. 38.
    Padwal RS, Pajewski NM, Allison DB, et al. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011;183(14):E1059–66.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Kuk JL, Ardern CI, Church TS, et al. Edmonton obesity staging system: association with weight history and mortality risk. Appl Physiol Nutr Metab. 2011;36(4):570–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Gill RS, Karmali S, Sharma AM. The potential role of the Edmonton obesity staging system in determining indications for bariatric surgery. Obes Surg. 2011;21(12):1947–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445–54.CrossRefGoogle Scholar
  42. 42.
    De Maria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis. 2007;3(2):134–40.CrossRefGoogle Scholar
  43. 43.
    Blackstone RP, Cortes MC. Metabolic acuity score: effect on major complications after bariatric surgery. Surg Obes Relat Dis. 2010;6(3):267–73.PubMedCrossRefGoogle Scholar
  44. 44.
    Guo X, Liu X, Wang M, et al. The effects of bariatric procedures versus medical therapy for obese patients with type 2 diabetes: meta-analysis of randomized controlled trials. Biomed Res Int. 2013;2013:410609.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.PubMedCrossRefGoogle Scholar
  46. 46.
    Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.PubMedCrossRefGoogle Scholar
  47. 47.
    Courcoulas AP, Belle SH, Neiberg RH, Pierson SK, Eagleton JK, Kalarchian MA, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 2015.Google Scholar
  48. 48.
    Zhuo X, Zhang P, Barker L, et al. The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care. 2014;37(9):2557–64.PubMedCrossRefGoogle Scholar
  49. 49.
    Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1–190. 215-357, iii-iv.CrossRefGoogle Scholar
  50. 50.
    Keating CL, Dixon JB, Moodie ML, et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care. 2009;32(4):567–74.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Hoerger TJ, Zhang P, Segel JE, et al. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 2010;33(9):1933–9.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Cremieux PY, Buchwald H, Shikora SA, et al. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008;14(9):589–96.PubMedGoogle Scholar
  53. 53.
    Warren JA, Ewing JA, Hale AL, et al. Cost-effectiveness of bariatric Surgery: increasing the economic viability of the most effective treatment for type II diabetes mellitus. Am Surg. 2015;81(8):807–11.PubMedGoogle Scholar
  54. 54.
    Li JF, Lai DD, Ni B, et al. Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Can J Surg. 2013;56(6):E158–64.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Yip S, Plank LD, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg. 2013;23(12):1994–2003.PubMedCrossRefGoogle Scholar
  56. 56.
    Zhang C, Yuan Y, Qiu C, et al. A meta-analysis of 2-year effect after surgery: laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity and diabetes mellitus. Obes Surg. 2014;24(9):1528–35.PubMedCrossRefGoogle Scholar
  57. 57.
    Yang X, Yang G, Wang W, et al. A meta-analysis: to compare the clinical results between gastric bypass and sleeve gastrectomy for the obese patients. Obes Surg. 2013;23(7):1001–10.PubMedCrossRefGoogle Scholar
  58. 58.
    Cho JM, Kim HJ, Menzo EL, et al. Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systemic review and meta-analysis. Surg Obes Relat Dis. 2015.Google Scholar
  59. 59.
    Wang MC, Guo XH, Zhang YW, et al. Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for obese patients with Type 2 diabetes: a meta-analysis of randomized controlled trials. Am Surg. 2015;81(2):166–71.PubMedGoogle Scholar
  60. 60.
    ASMBS Clinical Issues Committee. Bariatric surgery in class I obesity (body mass index 30–35 kg/m²). Surg Obes Relat Dis. 2013;9(1):e1–10.Google Scholar
  61. 61.
    Busetto L, Dixon J, De Luca M, et al. Bariatric surgery in class I obesity: a position statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2014;24(4):487–519.PubMedCrossRefGoogle Scholar
  62. 62.
    O’Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144(9):625–33.PubMedCrossRefGoogle Scholar
  63. 63.
    Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Li Q, Chen L, Yang Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index <35 kg/m2. Diabetes Obes Metab. 2012;14(3):262–70.Google Scholar
  65. 65.
    Reis CE, Alvarez-Leite JI, Bressan J, et al. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review. Diabetes Technol Ther. 2012;14(4):365–72.Google Scholar
  66. 66.
    Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010;6(3):254–9.PubMedCrossRefGoogle Scholar
  67. 67.
    DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6(3):249–53.PubMedCrossRefGoogle Scholar
  68. 68.
    Hall TC, Pellen MG, Sedman PC, et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010;20(9):1245–50.PubMedCrossRefGoogle Scholar
  69. 69.
    Hamza N, Abbas MH, Darwish A, et al. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis. 2011;7(6):691–6.PubMedCrossRefGoogle Scholar
  70. 70.
    Hawa MI, Kolb H, Schloot N, et al. Action LADA consortium. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care. 2013;36(4):908–13.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Manning SB, Pucci A, Batterham RL, et al. Latent autoimmune diabetes in adults presenting as diabetes “recurrence” after bariatric surgery: a case report. Diabetes Care. 2013;36(8):e120.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Kashyap SR, Schauer P. Clinical considerations for the management of residual diabetes following bariatric surgery. Diabetes Obes Metab. 2012;14(9):773–79.PubMedCrossRefGoogle Scholar
  73. 73.
    Deitel M. Update: why diabetes does not resolve in some patients after bariatric surgery. Obes Surg. 2011;21(6):794–6.PubMedCrossRefGoogle Scholar
  74. 74.
    Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery. 2010;147(5):664–9.PubMedCrossRefGoogle Scholar
  75. 75.
    Czupryniak L, Wiszniewski M, Szymański D, et al. Long-term results of gastric bypass surgery in morbidly obese type 1 diabetes patients. Obes Surg. 2010;20(4):506–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Mendez CE, Tanenberg RJ, Pories W. Outcomes of Roux-en-Y gastric bypass surgery for severely obese patients with type 1 diabetes: a case series report. Diabetes Metab Syndr Obes. 2010;3:281–3.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Reyes Garcia R, Romero Muñoz M, Galbis VH. Bariatric surgery in type 1 diabetes. Endocrinol Nutr. 2013;60(1):46–7.PubMedCrossRefGoogle Scholar
  78. 78.
    Breen DM, Rasmussen BA, Kokorovic A, et al. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med. 2012;18(6):950–5.PubMedCrossRefGoogle Scholar
  79. 79.
    Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993;44:121–31.PubMedCrossRefGoogle Scholar
  80. 80.
    Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62.PubMedCrossRefGoogle Scholar
  81. 81.
    Sattar N, McConnachie A, Shaper AG, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008;371(9628):1927–35.PubMedCrossRefGoogle Scholar
  82. 82.
    Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356–9.PubMedCrossRefGoogle Scholar
  83. 83.
    Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 2013;309(21):2250–61.PubMedCrossRefGoogle Scholar
  84. 84.
    Schauer PR, Bhatt DL, Kirwan JP, et al. STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.PubMedCrossRefGoogle Scholar
  85. 85.
    Kahn R. The metabolic syndrome (Emperor) wears no clothes. Diabetes Care. 2006;29(7):1693–6.CrossRefGoogle Scholar
  86. 86.
    Prospective Studies Collaboration, Whitlock G, Lewington S, et al. Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.PubMedCentralCrossRefGoogle Scholar
  87. 87.
    Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640–9.PubMedCrossRefGoogle Scholar
  88. 88.
    Batsis JA, Sarr MG, Collazo-Clavell ML, et al. Cardiovascular risk after bariatric surgery for obesity. Am J Cardiol. 2008;102(7):930–7.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Vest AR, Heneghan HM, Agarwal S, et al. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98(24):1763–77.PubMedCrossRefGoogle Scholar
  90. 90.
    Busetto L, De Stefano F, Pigozzo S, et al. Long-term cardiovascular risk and coronary events in morbidly obese patients treated with laparoscopic gastric banding. Surg Obes Relat Dis. 2014;10(1):112–20.PubMedCrossRefGoogle Scholar
  91. 91.
    Kwok CS, Pradhan A, Khan MA, et al. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol. 2014;173(1):20–8.PubMedCrossRefGoogle Scholar
  92. 92.
    Johnson BL, Blackhurst DW, Latham BB, et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg. 2013;216(4):545–56.PubMedCrossRefGoogle Scholar
  93. 93.
    Sturm W, Tschoner A, Engl J, et al. Effect of bariatric surgery on both functional and structural measures of premature atherosclerosis. Eur Heart J. 2009;30(16):2038–43.PubMedCrossRefGoogle Scholar
  94. 94.
    Tschoner A, Sturm W, Gelsinger C, et al. Long-term effects of weight loss after bariatric surgery on functional and structural markers of atherosclerosis. Obesity (Silver Spring). 2013;21(10):1960–5.CrossRefGoogle Scholar
  95. 95.
    Habib P, Scocco JD, Terek M, et al. Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis. Am J Cardiol. 2009;104(9):1251–5.PubMedCrossRefGoogle Scholar
  96. 96.
    Saleh MH, Bertolami MC, Assef JE, et al. Improvement of atherosclerotic markers in non-diabetic patients after bariatric surgery. Obes Surg. 2012;22(11):1701–7.PubMedCrossRefGoogle Scholar
  97. 97.
    Sarmento PLFA, Plavnik FL, Zanella MT, et al. Association of carotid intima-media thickness and cardiovascular risk factors in women pre- and post-bariatric surgery. Obes Surg. 2009;19(3):339–44.PubMedCrossRefGoogle Scholar
  98. 98.
    Nerla R, Tarzia P, Sestito A, et al. Effect of bariatric surgery on peripheral flow mediated dilation and coronary microvascular function. Nutr Metab Cardiovasc Dis. 2012;22(8):626–34.PubMedCrossRefGoogle Scholar
  99. 99.
    Priester T, Ault TG, Davidson L, et al. Coronary calcium scores 6 years after bariatric surgery. Obes Surg. 2015;25(1):90–6.Google Scholar
  100. 100.
    Lopez-Jimenez F, Bhatia S, Collazo-Clavell ML, et al. Safety and efficacy of bariatric surgery in patients with coronary artery disease. Mayo Clin Proc. 2005;80(9):1157–62.PubMedCrossRefGoogle Scholar
  101. 101.
    Afolabi BA, Novaro GM, Szomstein S, et al. Cardiovascular complications of obesity surgery in patients with increased preoperative cardiac risk. Surg Obes Relat Dis. 2009;5(6):653–6.PubMedCrossRefGoogle Scholar
  102. 102.
    Delling L, Karason K, Olbers T, Sjöström D, Wahlstrand B, Carlsson B, et al. Feasibility of bariatric surgery as a strategy for secondary prevention in cardiovascular disease: a report from the Swedish Obese Subjects trial. J Obes. 2010;2010.Google Scholar
  103. 103.
    Ramani GV, McCloskey C, Ramanathan RC, et al. Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin Cardiol. 2008;31(11):516–20.PubMedCrossRefGoogle Scholar
  104. 104.
    Miranda WR, Batsis JA, Sarr MG, et al. Impact of bariatric surgery on quality of life, functional capacity, and symptoms in patients with heart failure. Obes Surg. 2013;23(7):1011–5.PubMedCrossRefGoogle Scholar
  105. 105.
    Oreopoulos A, Padwal R, Kalantar-Zadeh K, et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156(1):13–22.PubMedCrossRefGoogle Scholar
  106. 106.
    Caceres M, Czer LS, Esmailian F, et al. Bariatric surgery in severe obesity and end-stage heart failure with mechanical circulatory support as a bridge to successful heart transplantation: a case report. Transplant Proc. 2013;45(2):798–9.PubMedCrossRefGoogle Scholar
  107. 107.
    Chaudhry UI, Kanji A, Sai-Sudhakar CB, et al. Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and left ventricular assist device: medium-term results. Surg Obes Relat Dis. 2015;11(1):88–93.PubMedCrossRefGoogle Scholar
  108. 108.
    Wikiel KJ, McCloskey CA, Ramanathan RC. Bariatric surgery: a safe and effective conduit to cardiac transplantation. Surg Obes Relat Dis. 2014;10(3):479–84.PubMedCrossRefGoogle Scholar
  109. 109.
    Sarkhosh K, Switzer NJ, El-Hadi M, et al. The impact of bariatric surgery on obstructive sleep apnea: a systematic review. Obes Surg. 2013;23(3):414–23.PubMedCrossRefGoogle Scholar
  110. 110.
    Tishler PV, Larkin EK, Schluchter MD, et al. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA. 2003;289(17):2230–7.PubMedCrossRefGoogle Scholar
  111. 111.
    Pannain S, Mokhlesi B. Bariatric surgery and its impact on sleep architecture, sleep-disordered breathing, and metabolism. Best Pract Res Clin Endocrinol Metab. 2010;24(5):745–61.PubMedCrossRefGoogle Scholar
  112. 112.
    Drager LF, Togeiro SM, Polotsky VY, et al. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol. 2013;62(7):569–76.PubMedPubMedCentralCrossRefGoogle Scholar
  113. 113.
    Dorkova Z, Petrasova D, Molcanyiova A, et al. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest. 2008;134(4):686–92.PubMedCrossRefGoogle Scholar
  114. 114.
    Sharma SK, Agrawal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med. 2011;365(24):2277–86.PubMedCrossRefGoogle Scholar
  115. 115.
    Dixon JB, Schachter LM, O’Brien PE, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;308(11):1142–9.PubMedCrossRefGoogle Scholar
  116. 116.
    Gupta RM, Parvizi J, Hanssen AD, et al. Postoperative complications in patients with obstructive sleep apnea syndrome undergoing hip or knee replacement: a case-control study. Mayo Clin Proc. 2001;76(9):897–905.PubMedCrossRefGoogle Scholar
  117. 117.
    Hwang D, Shakir N, Limann B, et al. Association of sleep-disordered breathing with postoperative complications. Chest. 2008;133(5):1128–34.PubMedCrossRefGoogle Scholar
  118. 118.
    Ferreyra GP, Baussano I, Squadrone V, et al. Continuous positive airway pressure for treatment of respiratory complications after abdominal surgery: a systematic review and meta-analysis. Ann Surg. 2008;247(4):617–26.PubMedCrossRefGoogle Scholar
  119. 119.
    Khan A, King WC, Patterson EJ, et al. Assessment of obstructive sleep apnea in adults undergoing bariatric surgery in the longitudinal assessment of bariatric surgery-2 (LABS-2) study. J Clin Sleep Med. 2013;9(1):21–9.PubMedPubMedCentralGoogle Scholar
  120. 120.
    O’Keeffe T, Patterson EJ. Evidence supporting routine polysomnography before bariatric surgery. Obes Surg. 2004;14(1):23–6.PubMedCrossRefGoogle Scholar
  121. 121.
    Sharkey KM, Orff HJ, Tosi C, et al. Subjective sleepiness and daytime functioning in bariatric patients with obstructive sleep apnea. Sleep Breath. 2013;17(1):267–74.PubMedCrossRefGoogle Scholar
  122. 122.
    Gasa M, Salord N, Fortuna AM, et al. Optimizing screening of severe obstructive sleep apnea in patients undergoing bariatric surgery. Surg Obes Relat Dis. 2013;9(4):539–46.PubMedCrossRefGoogle Scholar
  123. 123.
    Dixon JB, Schachter LM, O’Brien PE. Predicting sleep apnea and excessive day sleepiness in the severely obese: indicators for polysomnography. Chest. 2003;123(4):1134–41.PubMedCrossRefGoogle Scholar
  124. 124.
    Sareli AE, Cantor CR, Williams NN, et al. Obstructive sleep apnea in patients undergoing bariatric surgery—a tertiary center experience. Obes Surg. 2011;21(3):316–27.PubMedCrossRefGoogle Scholar
  125. 125.
    Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007;175(7):661–6.PubMedPubMedCentralCrossRefGoogle Scholar
  126. 126.
    Juel CT, Ali Z, Nilas L, et al. Asthma and obesity: does weight loss improve asthma control? a systematic review. J Asthma Allergy. 2012;5:21–6.PubMedPubMedCentralGoogle Scholar
  127. 127.
    Macgregor AM, Greenberg RA. Effect of surgically induced weight loss on asthma in the morbidly obese. Obes Surg. 1993;3(1):15–21.PubMedCrossRefGoogle Scholar
  128. 128.
    Dixon JB, Chapman L, O’Brien P. Marked improvement in asthma after Lap-Band surgery for morbid obesity. Obes Surg. 1999;9(4):385–9.PubMedCrossRefGoogle Scholar
  129. 129.
    Dávila-Cervantes A, Domínguez-Cherit G, Borunda D, et al. Impact of surgically-induced weight loss on respiratory function: a prospective analysis. Obes Surg. 2004;14(10):1389–92.PubMedCrossRefGoogle Scholar
  130. 130.
    Spivak H, Hewitt MF, Onn A, et al. Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure. Am J Surg. 2005;189(1):27–32.PubMedCrossRefGoogle Scholar
  131. 131.
    Dhabuwala A, Cannan RJ, Stubbs RS. Improvement in co-morbidities following weight loss from gastric bypass surgery. Obes Surg. 2000;10(5):428–35.PubMedCrossRefGoogle Scholar
  132. 132.
    Dixon AE, Pratley RE, Forgione PM, et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol. 2011;128(3):508–15.PubMedPubMedCentralCrossRefGoogle Scholar
  133. 133.
    van Huisstede A, Rudolphus A, Castro Cabezas M, et al. Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma. Thorax. 2015;70(7):659–67.PubMedCrossRefGoogle Scholar
  134. 134.
    Dandona P, Ghanim H, Monte SV, et al. Increase in the mediators of asthma in obesity and obesity with type 2 diabetes: reduction with weight loss. Obesity (Silver Spring). 2014;22(2):356–62.CrossRefGoogle Scholar
  135. 135.
    Blagojevic M, Jinks C, Jeffery A, et al. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2010;18(1):24–33.PubMedCrossRefGoogle Scholar
  136. 136.
    Grotle M, Hagen KB, Natvig B, et al. Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord. 2008;9:132.Google Scholar
  137. 137.
    Cooper C, Inskip H, Croft P, et al. Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol. 1998;147(6):516–22.PubMedCrossRefGoogle Scholar
  138. 138.
    Ackerman IN, Osborne RH. Obesity and increased burden of hip and knee joint disease in Australia: results from a national survey. BMC Musculoskelet Disord. 2012;13:254.PubMedPubMedCentralCrossRefGoogle Scholar
  139. 139.
    Christensen R, Bartels EM, Astrup A, et al. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2007;66(4):433–9.PubMedCentralCrossRefPubMedGoogle Scholar
  140. 140.
    Bordini B, Stea S, Cremonini S, et al. Relationship between obesity and early failure of total knee prostheses. BMC Musculoskelet Disord. 2009;10:29.PubMedPubMedCentralCrossRefGoogle Scholar
  141. 141.
    Kerkhoffs GM, Servien E, Dunn W, et al. The influence of obesity on the complication rate and outcome of total knee arthroplasty: a meta-analysis and systematic literature review. J Bone Joint Surg Am. 2012;94(20):1839–44.PubMedPubMedCentralCrossRefGoogle Scholar
  142. 142.
    Severson EP, Singh JA, Browne JA, et al. Total knee arthroplasty in morbidly obese patients treated with bariatric surgery: a comparative study. J Arthroplasty. 2012;27(9):1696–700.PubMedPubMedCentralCrossRefGoogle Scholar
  143. 143.
    Parvizi J, Trousdale RT, Sarr MG. Total joint arthroplasty in patients surgically treated for morbid obesity. J Arthroplasty. 2000;15(8):1003–8.PubMedCrossRefGoogle Scholar
  144. 144.
    Inacio MC, Paxton EW, Fisher D, et al. Bariatric surgery prior to total joint arthroplasty may not provide dramatic improvements in post-arthroplasty surgical outcomes. J Arthroplasty. 2014;29(7):1359–64.PubMedPubMedCentralCrossRefGoogle Scholar
  145. 145.
    Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101(11):2619–28.PubMedCrossRefGoogle Scholar
  146. 146.
    Eslick GD. Gastrointestinal symptoms and obesity: a meta-analysis. Obes Rev. 2012;13(5):469–79.PubMedCrossRefGoogle Scholar
  147. 147.
    El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53(9):2307–12.PubMedPubMedCentralCrossRefGoogle Scholar
  148. 148.
    Cai N, Ji GZ, Fan ZN, et al. Association between body mass index and erosive esophagitis: a meta-analysis. World J Gastroenterol. 2012;18(20):2545–53.PubMedPubMedCentralCrossRefGoogle Scholar
  149. 149.
    Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199–211.PubMedCrossRefGoogle Scholar
  150. 150.
    Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(5):872–8.PubMedCrossRefGoogle Scholar
  151. 151.
    Singh S, Sharma AN, Murad MH, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(11):1399–412. e7.PubMedCrossRefGoogle Scholar
  152. 152.
    Friedenberg FK, Xanthopoulos M, Foster GD, et al. The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol. 2008;103(8):2111–22.PubMedCrossRefGoogle Scholar
  153. 153.
    Ness-Jensen E, Lindam A, Lagergren J, et al. Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study. Am J Gastroenterol. 2013;108(3):376–82.PubMedCrossRefGoogle Scholar
  154. 154.
    Singh M, Lee J, Gupta N, et al. Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (Silver Spring). 2013;21(2):284–90.CrossRefGoogle Scholar
  155. 155.
    Patterson EJ, Davis DG, Khajanchee Y, et al. Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn. Surg Endosc. 2003;17(10):1561–5.PubMedCrossRefGoogle Scholar
  156. 156.
    Varela JE, Hinojosa MW, Nguyen NT. Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease. Surg Obes Relat Dis. 2009;5(2):139–43.PubMedCrossRefGoogle Scholar
  157. 157.
    Prachand VN, Alverdy JC. Gastroesophageal reflux disease and severe obesity: fundoplication or bariatric surgery? World J Gastroenterol. 2010;16(30):3757–61.PubMedPubMedCentralCrossRefGoogle Scholar
  158. 158.
    Ikramuddin S. Surgical management of gastroesophageal reflux disease in obesity. Dig Dis Sci. 2008;53(9):2318–29.PubMedCrossRefGoogle Scholar
  159. 159.
    Pallati PK, Shaligram A, Shostrom VK, et al. Improvement in gastroesophageal reflux disease symptoms after various bariatric procedures: review of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2014;10(3):502–7.PubMedCrossRefGoogle Scholar
  160. 160.
    Nelson LG, Gonzalez R, Haines K, et al. Amelioration of gastroesophageal reflux symptoms following Roux-en-Y gastric bypass for clinically significant obesity. Am Surg. 2005;71(11):950–3.PubMedGoogle Scholar
  161. 161.
    Tai CM, Lee YC, Wu MS, et al. The effect of Roux-en-Y gastric bypass on gastroesophageal reflux disease in morbidly obese Chinese patients. Obes Surg. 2009;19(5):565–70.PubMedCrossRefGoogle Scholar
  162. 162.
    Madalosso CA, Gurski RR, Callegari-Jacques SM, et al. The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity: a prospective study based on the Montreal Consensus. Ann Surg. 2010;251(2):244–8.PubMedCrossRefGoogle Scholar
  163. 163.
    Houghton SG, Romero Y, Sarr MG. Effect of Roux-en-Y gastric bypass in obese patients with Barrett’s esophagus: attempts to eliminate duodenogastric reflux. Surg Obes Relat Dis. 2008;4(1):1–4.PubMedCrossRefGoogle Scholar
  164. 164.
    Csendes A, Burgos AM, Smok G, et al. Effect of gastric bypass on Barrett’s esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg. 2006;10(2):259–64.PubMedCrossRefGoogle Scholar
  165. 165.
    Peterli R, Borbély Y, Kern B, et al. Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg. 2013;258(5):690–4.PubMedPubMedCentralCrossRefGoogle Scholar
  166. 166.
    Stefanidis D, Navarro F, Augenstein VA, et al. Laparoscopic fundoplication takedown with conversion to Roux-en-Y gastric bypass leads to excellent reflux control and quality of life after fundoplication failure. Surg Endosc. 2012;26(12):3521–7.PubMedCrossRefGoogle Scholar
  167. 167.
    Kim M, Navarro F, Eruchalu CN, et al. Minimally invasive Roux-en-Y gastric bypass for fundoplication failure offers excellent gastroesophageal reflux control. Am Surg. 2014;80(7):696–703.PubMedGoogle Scholar
  168. 168.
    de Jong JR, Besselink MG, van Ramshorst B, et al. Effects of adjustable gastric banding on gastroesophageal reflux and esophageal motility: a systematic review. Obes Rev. 2010;11(4):297–305.PubMedCrossRefGoogle Scholar
  169. 169.
    Klaus A, Gruber I, Wetscher G, et al. Prevalent esophageal body motility disorders underlie aggravation of GERD symptoms in morbidly obese patients following adjustable gastric banding. Arch Surg. 2006;141(3):247–51.PubMedCrossRefGoogle Scholar
  170. 170.
    Gagner M, Deitel M, Erickson AL, et al. Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes Surg. 2013;23(12):2013–7.PubMedCrossRefGoogle Scholar
  171. 171.
    Laffin M, Chau J, Gill RS, et al. Sleeve gastrectomy and gastroesophageal reflux disease. J Obes. 2013;2013:741097.PubMedPubMedCentralCrossRefGoogle Scholar
  172. 172.
    Chiu S, Birch DW, Shi X, et al. Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surg Obes Relat Dis. 2011;7(4):510–5.PubMedCrossRefGoogle Scholar
  173. 173.
    Gulkarov I, Wetterau M, Ren CJ, et al. Hiatal hernia repair at the initial laparoscopic adjustable gastric band operation reduces the need for reoperation. Surg Endosc. 2008;22(4):1035–41.PubMedCrossRefGoogle Scholar
  174. 174.
    Parikh MS, Fielding GA, Ren CJ. U.S. experience with 749 laparoscopic adjustable gastric bands: intermediate outcomes. Surg Endosc. 2005;19(12):1631–5.PubMedCrossRefGoogle Scholar
  175. 175.
    Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–85.PubMedCrossRefGoogle Scholar
  176. 176.
    Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, et al. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev. 2010;1:CD007340.PubMedGoogle Scholar
  177. 177.
    Bower G, Toma T, Harling L, Jiao LR, Efthimiou E, Darzi A, et al. Bariatric Surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology. Obes Surg. 2015.Google Scholar
  178. 178.
    Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142(7):1592–609.PubMedCrossRefGoogle Scholar
  179. 179.
    Rabl C, Campos GM. The impact of bariatric surgery on nonalcoholic steatohepatitis. Semin Liver Dis. 2012;32(1):80–91.PubMedCrossRefGoogle Scholar
  180. 180.
    Nagem RG, Lázaro-da-Silva A, de Oliveira RM, et al. Gallstone-related complications after Roux-en-Y gastric bypass: a prospective study. Hepatobiliary Pancreat Dis Int. 2012;11(6):630–5.PubMedCrossRefGoogle Scholar
  181. 181.
    Scopinaro N, Gianetta E, Civalleri D, et al. Two years of clinical experience with biliopancreatic bypass for obesity. Am J Clin Nutr. 1980;33(2 Suppl):506–14.PubMedGoogle Scholar
  182. 182.
    Tsirline VB, Keilani ZM, El Djouzi S, et al. How frequently and when do patients undergo cholecystectomy after bariatric surgery? Surg Obes Relat Dis. 2014;10(2):313–21.PubMedCrossRefGoogle Scholar
  183. 183.
    Sakorafas GH, Milingos D, Peros G. Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy. Dig Dis Sci. 2007;52(5):1313–25.Google Scholar
  184. 184.
    Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol. 1993;88(10):1705–10.PubMedGoogle Scholar
  185. 185.
    Bardaro SJ, Gagner M, Consten E, et al. Routine cholecystectomy during laparoscopic biliopancreatic diversion with duodenal switch is not necessary. Surg Obes Relat Dis. 2007;3(5):549–53.PubMedCrossRefGoogle Scholar
  186. 186.
    Malik S, Mitchell JE, Engel S, et al. Psychopathology in bariatric surgery candidates: a review of studies using structured diagnostic interviews. Compr Psychiatry. 2014;55(2):248–59.PubMedCrossRefGoogle Scholar
  187. 187.
    Lin HY, Huang CK, Tai CM, et al. Psychiatric disorders of patients seeking obesity treatment. BMC Psychiatr. 2013;13:1.CrossRefGoogle Scholar
  188. 188.
    Mühlhans B, Horbach T, de Zwaan M. Psychiatric disorders in bariatric surgery candidates: a review of the literature and results of a German prebariatric surgery sample. Gen Hosp Psychiatry. 2009;31(5):414–21.PubMedCrossRefGoogle Scholar
  189. 189.
    Kalarchian MA, Marcus MD, Levine MD, et al. Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. Am J Psychiatry. 2007;164(2):328–34.PubMedCrossRefGoogle Scholar
  190. 190.
    Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis. 2013;9(2):159–91.PubMedCrossRefGoogle Scholar
  191. 191.
    Eldar S, Heneghan HM, Brethauer S, et al. A focus on surgical preoperative evaluation of the bariatric patient—the Cleveland Clinic protocol and review of the literature. Surgeon. 2011;9(5):273–7.PubMedCrossRefGoogle Scholar
  192. 192.
    Pickering RP, Grant BF, Chou SP, et al. Are overweight, obesity, and extreme obesity associated with psychopathology? Results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2007;68(7):998–1009.PubMedCrossRefGoogle Scholar
  193. 193.
    Mitchell JE, Selzer F, Kalarchian MA, et al. Psychopathology before surgery in the longitudinal assessment of bariatric surgery-3 (LABS-3) psychosocial study. Surg Obes Relat Dis. 2012;8(5):533–41.PubMedPubMedCentralCrossRefGoogle Scholar
  194. 194.
    Livhits M, Mercado C, Yermilov I, et al. Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg. 2012;22(1):70–89.PubMedCrossRefGoogle Scholar
  195. 195.
    de Zwaan M, Enderle J, Wagner S, et al. Anxiety and depression in bariatric surgery patients: a prospective, follow-up study using structured clinical interviews. J Affect Disord. 2011;133(1-2):61–8.PubMedCrossRefGoogle Scholar
  196. 196.
    Legenbauer T, De Zwaan M, Benecke A, et al. Depression and anxiety: their predictive function for weight loss in obese individuals. Obes Facts. 2009;2(4):227–34.PubMedCrossRefGoogle Scholar
  197. 197.
    Brunault P, Jacobi D, Miknius V, et al. High preoperative depression, phobic anxiety, and binge eating scores and low medium-term weight loss in sleeve gastrectomy obese patients: a preliminary cohort study. Psychosomatics. 2012;53(4):363–70.PubMedCrossRefGoogle Scholar
  198. 198.
    Edwards-Hampton SA, Madan A, Wedin S, et al. A closer look at the nature of anxiety in weight loss surgery candidates. Int J Psychiatry Med. 2014;47(2):105–13.PubMedCrossRefGoogle Scholar
  199. 199.
    Singh M. Mood, food, and obesity. Front Psychol. 2014;5:925.PubMedPubMedCentralCrossRefGoogle Scholar
  200. 200.
    Meye FJ, Adan RA. Feelings about food: the ventral tegmental area in food reward and emotional eating. Trends Pharmacol Sci. 2014;35(1):31–40.PubMedCrossRefGoogle Scholar
  201. 201.
    Akubuiro A, Bridget Zimmerman M, Boles Ponto LL, et al. Hyperactive hypothalamus, motivated and non-distractible chronic overeating in ADAR2 transgenic mice. Genes Brain Behav. 2013;12(3):311–22.PubMedPubMedCentralCrossRefGoogle Scholar
  202. 202.
    Hryhorczuk C, Sharma S, Fulton SE. Metabolic disturbances connecting obesity and depression. Front Neurosci. 2013;7:177.PubMedPubMedCentralCrossRefGoogle Scholar
  203. 203.
    Sharma S, Fulton S. Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry. Int J Obes (Lond). 2013;37(3):382–9.CrossRefGoogle Scholar
  204. 204.
    Kok P, Roelfsema F, Frölich M, et al. Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women. Am J Physiol Endocrinol Metab. 2006;291(5):E1038–43.PubMedCrossRefGoogle Scholar
  205. 205.
    Ahmed AT, Warton EM, Schaefer CA, et al. The effect of bariatric surgery on psychiatric course among patients with bipolar disorder. Bipolar Disord. 2013;15(7):753–63.PubMedPubMedCentralCrossRefGoogle Scholar
  206. 206.
    Yska JP, van der Linde S, Tapper VV, et al. Influence of bariatric surgery on the use and pharmacokinetics of some major drug classes. Obes Surg. 2013;23(6):819–25.PubMedCrossRefGoogle Scholar
  207. 207.
    Cunningham JL, Merrell CC, Sarr M, et al. Investigation of antidepressant medication usage after bariatric surgery. Obes Surg. 2012;22(4):530–5.PubMedCrossRefGoogle Scholar
  208. 208.
    Smith A, Henriksen B, Cohen A. Pharmacokinetic considerations in Roux-en-Y gastric bypass patients. Am J Health Syst Pharm. 2011;68(23):2241–7.PubMedCrossRefGoogle Scholar
  209. 209.
    Brietzke E, Lafer B. Long-acting injectable risperidone in a bipolar patient submitted to bariatric surgery and intolerant to conventional mood stabilizers. Psychiatry Clin Neurosci. 2011;65(2):205.PubMedCrossRefGoogle Scholar
  210. 210.
    Tripp AC. Lithium toxicity after Roux-en-Y gastric bypass surgery. J Clin Psychopharmacol. 2011;31(2):261–2.PubMedCrossRefGoogle Scholar
  211. 211.
    Pramyothin P, Khaodhiar L. Metabolic syndrome with the atypical antipsychotics. Curr Opin Endocrinol Diabetes Obes. 2010;17(5):460–6.PubMedCrossRefGoogle Scholar
  212. 212.
    Deeks ED. Risperidone long-acting injection: in bipolar I disorder. Drugs. 2010;70(8):1001–12.PubMedCrossRefGoogle Scholar
  213. 213.
    Bobbioni-Harsch E, Guillermin ML, Habicht F. Reciprocal interactions between bariatric surgery and psychopathology. Rev Med Suisse. 2014;10(442):1721–6. French.PubMedGoogle Scholar
  214. 214.
    Svensson PA, Anveden Å, Romeo S, et al. Alcohol consumption and alcohol problems after bariatric surgery in the Swedish Obese Subjects study. Obesity (Silver Spring). 2013;21(12):2444–51.CrossRefGoogle Scholar
  215. 215.
    Kudsi OY, Huskey K, Grove S, et al. Prevalence of preoperative alcohol abuse among patients seeking weight-loss surgery. Surg Endosc. 2013;27(4):1093–7.PubMedCrossRefGoogle Scholar
  216. 216.
    Heinberg LJ, Ashton K, Coughlin J. Alcohol and bariatric surgery: review and suggested recommendations for assessment and management. Surg Obes Relat Dis. 2012;8(3):357–63.PubMedCrossRefGoogle Scholar
  217. 217.
    Suzuki J, Haimovici F, Chang G. Alcohol use disorders after bariatric surgery. Obes Surg. 2012;22(2):201–7.PubMedCrossRefGoogle Scholar
  218. 218.
    Ertelt TW, Mitchell JE, Lancaster K, et al. Alcohol abuse and dependence before and after bariatric surgery: a review of the literature and report of a new data set. Surg Obes Relat Dis. 2008;4(5):647–50.PubMedCrossRefGoogle Scholar
  219. 219.
    Saules KK, Wiedemann A, Ivezaj V, et al. Bariatric surgery history among substance abuse treatment patients: prevalence and associated features. Surg Obes Relat Dis. 2010;6(6):615–21.PubMedCrossRefGoogle Scholar
  220. 220.
    King WC, Chen JY, Mitchell JE, et al. Prevalence of alcohol use disorders before and after bariatric surgery. JAMA. 2012;307(23):2516–25.PubMedPubMedCentralCrossRefGoogle Scholar
  221. 221.
    Ostlund MP, Backman O, Marsk R, et al. Increased admission for alcohol dependence after gastric bypass surgery compared with restrictive bariatric surgery. JAMA Surg. 2013;148(4):374–7.PubMedCrossRefGoogle Scholar
  222. 222.
    Polston JE, Pritchett CE, Tomasko JM, et al. Roux-en-Y gastric bypass increases intravenous ethanol self-administration in dietary obese rats. PLoS One. 2013;8(12):e83741.PubMedCrossRefPubMedCentralGoogle Scholar
  223. 223.
    Maluenda F, Csendes A, De Aretxabala X, et al. Alcohol absorption modification after a laparoscopic sleeve gastrectomy due to obesity. Obes Surg. 2010;20(6):744–8.PubMedCrossRefGoogle Scholar
  224. 224.
    Thanos PK, Subrize M, Delis F, et al. Gastric bypass increases ethanol and water consumption in diet-induced obese rats. Obes Surg. 2012;22(12):1884–92.PubMedPubMedCentralCrossRefGoogle Scholar
  225. 225.
    McCormick LM, Buchanan JR, Onwuameze OE, et al. Beyond alcoholism: Wernicke-Korsakoff syndrome in patients with psychiatric disorders. Cogn Behav Neurol. 2011;24(4):209–16.PubMedPubMedCentralCrossRefGoogle Scholar
  226. 226.
    Ashton K, Heinberg L, Merrell J, et al. Pilot evaluation of a substance abuse prevention group intervention for at-risk bariatric surgery candidates. Surg Obes Relat Dis. 2013;9(3):462–7.PubMedCrossRefGoogle Scholar
  227. 227.
    Blum K, Bailey J, Gonzalez AM, Oscar-Berman M, Liu Y, Giordano J, et al. Neuro-genetics of reward deficiency syndrome (RDS) as the root cause of “addiction transfer”: a new phenomenon common after bariatric surgery. J Genet Syndr Gene Ther. 2011;2012(1).Google Scholar
  228. 228.
    Snyder AG. Psychological assessment of the patient undergoing bariatric surgery. Ochsner J. 2009;9(3):144–8.PubMedPubMedCentralGoogle Scholar
  229. 229.
    Friedman KE, Applegate KL, Grant J. Who is adherent with preoperative psychological treatment recommendations among weight loss surgery candidates? Surg Obes Relat Dis. 2007;3(3):376–82.PubMedCrossRefGoogle Scholar
  230. 230.
    Parker K, O’Brien P, Brennan L. Measurement of disordered eating following bariatric surgery: a systematic review of the literature. Obes Surg. 2014;24(6):945–53.PubMedCrossRefGoogle Scholar
  231. 231.
    Morrow J, Gluck M, Lorence M, et al. Night eating status and influence on body weight, body image, hunger, and cortisol pre- and post- Roux-en-Y Gastric Bypass (RYGB) surgery. Eat Weight Disord. 2008;13(4):e96–9.PubMedPubMedCentralCrossRefGoogle Scholar
  232. 232.
    Colles SL, Dixon JB. Night eating syndrome: impact on bariatric surgery. Obes Surg. 2006;16(7):811–20.PubMedCrossRefGoogle Scholar
  233. 233.
    Fierabracci P, Pinchera A, Martinelli S, et al. Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes. Obes Surg. 2011;21(1):54–60.PubMedCrossRefGoogle Scholar
  234. 234.
    Poirier P, Alpert MA, Fleisher LA, et al. Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association. Circulation. 2009;120(1):86–95.PubMedCrossRefGoogle Scholar
  235. 235.
    Stocker DJ. Management of the bariatric surgery patient. Endocrinol Metab Clin North Am. 2003;32(2):437–57.PubMedCrossRefGoogle Scholar
  236. 236.
    DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007;356(21):2176–83.PubMedCrossRefGoogle Scholar
  237. 237.
    Ness-Abramof R, Nabriski D, Apovian CM, et al. Overnight dexamethasone suppression test: a reliable screen for Cushing’s syndrome in the obese. Obes Res. 2002;10(12):1217–21.PubMedCrossRefGoogle Scholar
  238. 238.
    Collazo-Clavell ML, Clark MM, McAlpine DE, et al. Assessment and preparation of patients for bariatric surgery. Mayo Clin Proc. 2006;81(10 Suppl):S11–7.PubMedCrossRefGoogle Scholar
  239. 239.
    Manco M, Nanni G, Tondolo V, et al. Hypocalcemia complicating near-total thyroidectomy in patients with coexisting lipid malabsorption due to biliopancreatic diversion. Obes Surg. 2004;14(10):1429–34.PubMedCrossRefGoogle Scholar
  240. 240.
    Pietras SM, Holick MF. Refractory hypocalcemia following near-total thyroidectomy in a patient with a prior Roux-en-Y gastric bypass. Obes Surg. 2009;19(4):524–6.PubMedCrossRefGoogle Scholar
  241. 241.
    Shah M, Simha V, Garg A. Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab. 2006;91(11):4223–31.PubMedCrossRefGoogle Scholar
  242. 242.
    Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95(11):4823–43.PubMedCrossRefGoogle Scholar
  243. 243.
    Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8(1):48–55.PubMedCrossRefGoogle Scholar
  244. 244.
    Rojas-Marcos PM, Rubio MA, Kreskshi WI, et al. Severe hypocalcemia following total thyroidectomy after biliopancreatic diversion. Obes Surg. 2005;15(3):431–4.PubMedCrossRefGoogle Scholar
  245. 245.
    Dalbeth N, Chen P, White M, et al. Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study. Ann Rheum Dis. 2014;73(5):797–802.PubMedCrossRefGoogle Scholar
  246. 246.
    Romero-Talamás H, Daigle CR, Aminian A, et al. The effect of bariatric surgery on gout: a comparative study. Surg Obes Relat Dis. 2014;10(6):1161–5.PubMedCrossRefGoogle Scholar
  247. 247.
    Bergendal A, Bremme K, Hedenmalm K, et al. Risk factors for venous thromboembolism in pre-and postmenopausal women. Thromb Res. 2012;130(4):596–601.PubMedCrossRefGoogle Scholar
  248. 248.
    Laliberté F, Dea K, Duh MS, et al. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy. Menopause. 2011;18(10):1052–9.PubMedCrossRefGoogle Scholar
  249. 249.
    Canonico M, Oger E, Conard J, et al. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. ESTHER Study J Thromb Haemost. 2006;4(6):1259–65.PubMedCrossRefGoogle Scholar
  250. 250.
    Pandey S, Pandey S, Maheshwari A, et al. The impact of female obesity on the outcome of fertility treatment. J Hum Reprod Sci. 2010;3(2):62–7.PubMedPubMedCentralCrossRefGoogle Scholar
  251. 251.
    Rich-Edwards JW, Goldman MB, Willett WC, et al. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol. 1994;171(1):171–7.PubMedCrossRefGoogle Scholar
  252. 252.
    van der Steeg JW, Steures P, Eijkemans MJ, et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2008;23(2):324–8.PubMedCrossRefGoogle Scholar
  253. 253.
    Gil-Campos M, Cañete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr. 2004;23(5):963–74.PubMedCrossRefGoogle Scholar
  254. 254.
    Motta AB. The role of obesity in the development of polycystic ovary syndrome. Curr Pharm Des. 2012;18(17):2482–91.PubMedCrossRefGoogle Scholar
  255. 255.
    Baeten JM, Bukusi EA, Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health. 2001;91(3):436–40.PubMedPubMedCentralCrossRefGoogle Scholar
  256. 256.
    Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004;103(2):219–24.PubMedCrossRefGoogle Scholar
  257. 257.
    Sebire NJ, Jolly M, Harris JP, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord. 2001;25(8):1175–82.PubMedCrossRefGoogle Scholar
  258. 258.
    Weiss JL, Malone FD, Emig D, et al. Obesity, obstetric complications and cesarean delivery rate—a population-based screening study. Am J Obstet Gynecol. 2004;190(4):1091–7.PubMedCrossRefGoogle Scholar
  259. 259.
    Stothard KJ, Tennant PW, Bell R, et al. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA. 2009;301(6):636–50.PubMedCrossRefGoogle Scholar
  260. 260.
    Oken E, Taveras EM, Kleinman KP, et al. Gestational weight gain and child adiposity at age 3 years. Am J Obstet Gynecol. 2007;196(4):322.e1–8.Google Scholar
  261. 261.
    American College of Obstetricians and Gynecologists. ACOG committee opinion no. 549: obesity in pregnancy. Obstet Gynecol. 2013;121(1):213–7.CrossRefGoogle Scholar
  262. 262.
    Sheiner E, Levy A, Silverberg D, et al. Pregnancy after bariatric surgery is not associated with adverse perinatal outcome. Am J Obstet Gynecol. 2004;190(5):1335–40.PubMedCrossRefGoogle Scholar
  263. 263.
    Martin LF, Finigan KM, Nolan TE. Pregnancy after adjustable gastric banding. Obstet Gynecol. 2000;95(6 Pt 1):927–30.PubMedGoogle Scholar
  264. 264.
    McTiernan A. Obesity and cancer: the risks, science, and potential management strategies. Oncology (Williston Park). 2005;19(7):871–81.Google Scholar
  265. 265.
    Anderson AS, Caswell S. Obesity management—an opportunity for cancer prevention. Surgeon. 2009;7(5):282–5.PubMedCrossRefGoogle Scholar
  266. 266.
    Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol. 2002;3(9):565–74.PubMedCrossRefGoogle Scholar
  267. 267.
    Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–38.PubMedCrossRefGoogle Scholar
  268. 268.
    Tee MC, Cao Y, Warnock GL, et al. Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis. Surg Endosc. 2013;27(12):4449–56.PubMedPubMedCentralCrossRefGoogle Scholar
  269. 269.
    Casagrande DS, Rosa DD, Umpierre D, et al. Incidence of cancer following bariatric surgery: systematic review and meta-analysis. Obes Surg. 2014;24(9):1499–509.PubMedCrossRefGoogle Scholar
  270. 270.
    Afshar S, Kelly SB, Seymour K, et al. The effects of bariatric surgery on colorectal cancer risk: systematic review and meta-analysis. Obes Surg. 2014;24(10):1793–9.PubMedCrossRefGoogle Scholar
  271. 271.
    Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335(7630):1134.PubMedPubMedCentralCrossRefGoogle Scholar
  272. 272.
    Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78.PubMedCrossRefGoogle Scholar
  273. 273.
    Renehan AG, Soerjomataram I, Tyson M, et al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer. 2010;126(3):692–702.PubMedCrossRefGoogle Scholar
  274. 274.
    Eliassen AH, Colditz GA, Rosner B, et al. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296(2):193–201.PubMedCrossRefGoogle Scholar
  275. 275.
    Lahmann PH, Lissner L, Gullberg B, et al. A prospective study of adiposity and postmenopausal breast cancer risk: the Malmö Diet and Cancer Study. Int J Cancer. 2003;103(2):246–52.PubMedCrossRefGoogle Scholar
  276. 276.
    Chang SH, Pollack LM, Colditz GA. Obesity, mortality, and life years lost associated with breast cancer in nonsmoking US Women, National Health Interview Survey, 1997–2000. Prev Chronic Dis. 2013;10:E186.PubMedPubMedCentralCrossRefGoogle Scholar
  277. 277.
    Minicozzi P, Berrino F, Sebastiani F, et al. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease. Eur J Cancer. 2013;49(18):3881–8.PubMedCrossRefGoogle Scholar
  278. 278.
    Petrelli JM, Calle EE, Rodriguez C, et al. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control. 2002;13(4):325–32.PubMedCrossRefGoogle Scholar
  279. 279.
    Howell A, Sims AH, Ong KR, et al. Mechanisms of disease: prediction and prevention of breast cancer—cellular and molecular interactions. Nat Clin Pract Oncol. 2005;2(12):635–46.PubMedCrossRefGoogle Scholar
  280. 280.
    Harvie M, Howell A, Vierkant RA, et al. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women’s health study. Cancer Epidemiol Biomarkers Prev. 2005;14(3):656–61.PubMedCrossRefGoogle Scholar
  281. 281.
    Havrilesky LJ, Maxwell GL, Myers ER. Cost-effectiveness analysis of annual screening strategies for endometrial cancer. Am J Obstet Gynecol. 2009;200(6):640.e1–8.CrossRefGoogle Scholar
  282. 282.
    Kwon JS, Lu KH. Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women. Obstet Gynecol. 2008;112(1):56–63.PubMedCrossRefGoogle Scholar
  283. 283.
    Rose PG. Endometrial carcinoma. N Engl J Med. 1996;335(9):640–9.PubMedCrossRefGoogle Scholar
  284. 284.
    von Gruenigen VE, Tian C, Frasure H, et al. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study. Cancer. 2006;107(12):2786–91.CrossRefGoogle Scholar
  285. 285.
    Arem H, Park Y, Pelser C, et al. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst. 2013;105(5):342–9.PubMedPubMedCentralCrossRefGoogle Scholar
  286. 286.
    Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1531–43.PubMedGoogle Scholar
  287. 287.
    McCawley GM, Ferriss JS, Geffel D, et al. Cancer in obese women: potential protective impact of bariatric surgery. J Am Coll Surg. 2009;208(6):1093–8.PubMedCrossRefGoogle Scholar
  288. 288.
    Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009;17(4):796–802.CrossRefGoogle Scholar
  289. 289.
    Ward KK, Roncancio AM, Shah NR, et al. Bariatric surgery decreases the risk of uterine malignancy. Gynecol Oncol. 2014;133(1):63–6.PubMedCrossRefGoogle Scholar
  290. 290.
    Gagné DJ, Papasavas PK, Maalouf M, et al. Obesity surgery and malignancy: our experience after 1500 cases. Surg Obes Relat Dis. 2009;5(2):160–4.PubMedCrossRefGoogle Scholar
  291. 291.
    Potluri K, Hou S. Obesity in kidney transplant recipients and candidates. Am J Kidney Dis. 2010;56(1):143–56.PubMedCrossRefGoogle Scholar
  292. 292.
    Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol. 2004;2(12):1048–58.PubMedCrossRefGoogle Scholar
  293. 293.
    Kemmer N, Neff GW, Franco E, et al. Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation. Transplantation. 2013;96(10):860–2.PubMedGoogle Scholar
  294. 294.
    Leonard J, Heimbach JK, Malinchoc M, et al. The impact of obesity on long-term outcomes in liver transplant recipients—results of the NIDDK liver transplant database. Am J Transplant. 2008;8(3):667–72.PubMedCrossRefGoogle Scholar
  295. 295.
    Conzen KD, Vachharajani N, Collins KM, et al. Morbid obesity in liver transplant recipients adversely affects long-term graft and patient survival in a single-institution analysis. HPB (Oxford). 2015;17(3):251–7.CrossRefGoogle Scholar
  296. 296.
    Hakeem AR, Cockbain AJ, Raza SS, et al. Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl. 2013;19(5):551–62.PubMedCrossRefGoogle Scholar
  297. 297.
    Pieloch D, Dombrovskiy V, Osband AJ, et al. Morbid obesity is not an independent predictor of graft failure or patient mortality after kidney transplantation. J Ren Nutr. 2014;24(1):50–7.PubMedCrossRefGoogle Scholar
  298. 298.
    Curran SP, Famure O, Li Y, Kim SJ. Increased recipient body mass index is associated with acute rejection and other adverse outcomes after kidney transplantation. Transplantation. 2014;97(1):64–70.PubMedCrossRefGoogle Scholar
  299. 299.
    McCloskey CA, Ramani GV, Mathier MA, et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis. 2007;3(5):503–7.PubMedCrossRefGoogle Scholar
  300. 300.
    Newcombe V, Blanch A, Slater GH, et al. Laparoscopic adjustable gastric banding prior to renal transplantation. Obes Surg. 2005;15(4):567–70.PubMedCrossRefGoogle Scholar
  301. 301.
    Campsen J, Zimmerman M, Shoen J, et al. Adjustable gastric banding in a morbidly obese patient during liver transplantation. Obes Surg. 2008;18(12):1625–7.PubMedCrossRefGoogle Scholar
  302. 302.
    Porubsky M, Powelson JA, Selzer DJ, et al. Pancreas transplantation after bariatric surgery. Clin Transplant. 2012;26(1):E1–6.PubMedCrossRefGoogle Scholar
  303. 303.
    Al-Sabah S, Christou NV. Laparoscopic gastric bypass after cardiac transplantation. Surg Obes Relat Dis. 2008;4(5):668–70.PubMedCrossRefGoogle Scholar
  304. 304.
    Lin MY, Tavakol MM, Sarin A, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg Endosc. 2013;27(1):81–5.PubMedCrossRefGoogle Scholar
  305. 305.
    Al-Nowaylati AR, Al-Haddad BJ, Dorman RB, et al. Gastric bypass after liver transplantation. Liver Transpl. 2013;19(12):1324–9.PubMedCrossRefGoogle Scholar
  306. 306.
    Duchini A, Brunson ME. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity. Transplantation. 2001;72(1):156–9.PubMedCrossRefGoogle Scholar
  307. 307.
    Takata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008;4(2):159–64.PubMedCrossRefGoogle Scholar
  308. 308.
    Lin MY, Tavakol MM, Sarin A, et al. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis. 2013;9(5):653–8.PubMedCrossRefGoogle Scholar
  309. 309.
    Lazzati A, Iannelli A, Schneck AS, et al. Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery. Obes Surg. 2015;25(1):134–42.PubMedCrossRefGoogle Scholar
  310. 310.
    Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59(10):1492–5.PubMedCrossRefGoogle Scholar
  311. 311.
    Wakerley BR, Tan MH, Ting EY. Idiopathic intracranial hypertension. Cephalalgia. 2015;35(3):248–61.PubMedCrossRefGoogle Scholar
  312. 312.
    Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2012;83(5):488–94.PubMedPubMedCentralCrossRefGoogle Scholar
  313. 313.
    Curry Jr WT, Butler WE, Barker 2nd FG. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988–2002. Neurosurgery. 2005;57(1):97–108.PubMedCrossRefGoogle Scholar
  314. 314.
    Sugerman HJ, DeMaria EJ, Felton III WL, et al. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology. 1997;49(2):507–11.PubMedCrossRefGoogle Scholar
  315. 315.
    Menger RP, Connor Jr DE, Thakur JD, et al. A comparison of lumboperitoneal and ventriculoperitoneal shunting for idiopathic intracranial hypertension: an analysis of economic impact and complications using the Nationwide Inpatient Sample. Neurosurg Focus. 2014;37(5):E4.PubMedCrossRefGoogle Scholar
  316. 316.
    Sugerman HJ, Felton 3rd WL, Sismanis A, et al. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg. 1999;229(5):634–40.PubMedPubMedCentralCrossRefGoogle Scholar
  317. 317.
    Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341:c2701.PubMedPubMedCentralCrossRefGoogle Scholar
  318. 318.
    Newborg B. Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med. 1974;133(5):802–7.PubMedCrossRefGoogle Scholar
  319. 319.
    Kupersmith MJ, Gamell L, Turbin R, et al. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998;50(4):1094–8.PubMedCrossRefGoogle Scholar
  320. 320.
    Johnson LN, Krohel GB, Madsen RW, et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998;105(12):2313–7.PubMedCrossRefGoogle Scholar
  321. 321.
    Glueck CJ, Golnik KC, Aregawi D, et al. Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia. Transl Res. 2006;148(5):215–22.PubMedCrossRefGoogle Scholar
  322. 322.
    Sugerman HJ, Felton 3rd WL, Salvant Jr JB, et al. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology. 1995;45(9):1655–9.PubMedCrossRefGoogle Scholar
  323. 323.
    Chandra V, Dutta S, Albanese CT, et al. Clinical resolution of severely symptomatic pseudotumor cerebri after gastric bypass in an adolescent. Surg Obes Relat Dis. 2007;3(2):198–200.PubMedCrossRefGoogle Scholar
  324. 324.
    Nadkarni T, Rekate HL, Wallace D. Resolution of pseudotumor cerebri after bariatric surgery for related obesity. Case report J Neurosurg. 2004;101(5):878–80.PubMedGoogle Scholar
  325. 325.
    Levin AA, Hess D, Hohler AD. Treatment of idiopathic intracranial hypertension with gastric bypass surgery. Int J Neurosci. 2015;125(1):78–80.PubMedCrossRefGoogle Scholar
  326. 326.
    Fridley J, Foroozan R, Sherman V, et al. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg. 2011;114(1):34–9.PubMedCrossRefGoogle Scholar
  327. 327.
    Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–7.PubMedCrossRefGoogle Scholar
  328. 328.
    Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111–9.PubMedPubMedCentralCrossRefGoogle Scholar
  329. 329.
    Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752–61.PubMedPubMedCentralCrossRefGoogle Scholar
  330. 330.
    Netzer N, Gatterer H, Faulhaber M, et al. Hypoxia, oxidative stress and fat. Biomolecules. 2015;5(2):1143–50.PubMedPubMedCentralCrossRefGoogle Scholar
  331. 331.
    Schmidt FM, Weschenfelder J, Sander C, et al. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One. 2015;10(3):e0121971.PubMedPubMedCentralCrossRefGoogle Scholar
  332. 332.
    Nijhuis J, Rensen SS, Slaats Y, et al. Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring). 2009;17(11):2014–8.CrossRefGoogle Scholar
  333. 333.
    Hu T, Li LF, Shen J, et al. Chronic inflammation and colorectal cancer: the role of vascular endothelial growth factor. Curr Pharm Des. 2015;21(21):2960–7.PubMedCrossRefGoogle Scholar
  334. 334.
    Tilg H, Moschen AR. Mechanisms behind the link between obesity and gastrointestinal cancers. Best Pract Res Clin Gastroenterol. 2014;28(4):599–610.PubMedCrossRefGoogle Scholar
  335. 335.
    Long E, Beales IL. The role of obesity in oesophageal cancer development. Therap Adv Gastroenterol. 2014;7(6):247–68.PubMedPubMedCentralCrossRefGoogle Scholar
  336. 336.
    Cottam D, Fisher B, Ziemba A, et al. Tumor growth factor expression in obesity and changes in expression with weight loss: another cause of increased virulence and incidence of cancer in obesity. Surg Obes Relat Dis. 2010;6(5):538–41.PubMedCrossRefGoogle Scholar
  337. 337.
    Cottam DR, Schaefer PA, Shaftan GW, et al. Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obes Surg. 2002;12(3):335–42.PubMedCrossRefGoogle Scholar
  338. 338.
    van Dielen FM, Buurman WA, Hadfoune M, et al. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab. 2004;89(8):4062–8.PubMedCrossRefGoogle Scholar
  339. 339.
    Hanusch-Enserer U, Cauza E, Spak M, et al. Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord. 2003;27(3):355–61.PubMedCrossRefGoogle Scholar
  340. 340.
    Santos J, Salgado P, Santos C, et al. Effect of bariatric surgery on weight loss, inflammation, iron metabolism, and lipid profile. Scand J Surg. 2014;103(1):21–5.PubMedCrossRefGoogle Scholar
  341. 341.
    Carlsson LM, Romeo S, Jacobson P, et al. The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial. Int J Obes (Lond). 2015;39(1):169–75.CrossRefGoogle Scholar
  342. 342.
    Miras AD, le Roux CW. Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health. Lancet Diabetes Endocrinol. 2014;2(2):141–51.PubMedCrossRefGoogle Scholar
  343. 343.
    Navaneethan SD, Yehnert H, Moustarah F, et al. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4(10):1565–74.PubMedPubMedCentralCrossRefGoogle Scholar
  344. 344.
    Iaconelli A, Panunzi S, De Gaetano A, et al. Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care. 2011;34(3):561–7.PubMedPubMedCentralCrossRefGoogle Scholar
  345. 345.
    Miras AD, Chuah LL, Lascaratos G, et al. Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care. 2012;35(12):e81.PubMedPubMedCentralCrossRefGoogle Scholar
  346. 346.
    Fenske WK, Dubb S, Bueter M, et al. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis. 2013;9(4):559–68.PubMedCrossRefGoogle Scholar
  347. 347.
    Heneghan HM, Cetin D, Navaneethan SD, et al. Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis. 2013;9(1):7–14.Google Scholar
  348. 348.
    Navaneethan SD, Malin SK, Arrigain S, et al. Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study. Am J Kidney Dis. 2015;65(2):345–7.PubMedCrossRefGoogle Scholar
  349. 349.
    Jamal MH, Corcelles R, Daigle CR, et al. Safety and effectiveness of bariatric surgery in dialysis patients and kidney transplantation candidates. Surg Obes Relat Dis. 2015;11(2):419–23.PubMedCrossRefGoogle Scholar
  350. 350.
    Modanlou KA, Muthyala U, Xiao H, et al. Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation. 2009;87(8):1167–73.PubMedPubMedCentralCrossRefGoogle Scholar
  351. 351.
    Lafranca JA, JN IJ, Betjes MG, Dor FJ. Body mass index and outcome in renal transplant recipients: a systematic review and meta-analysis. BMC Med. 2015;13(1):111. Erratum in BMC Med. 2015;13:141.Google Scholar
  352. 352.
    Subak LL, King WC, Belle SH, et al. Urinary incontinence before and after bariatric surgery. JAMA Intern Med. 2015;175(8):1378–87.PubMedPubMedCentralCrossRefGoogle Scholar
  353. 353.
    Steele T, Cuthbertson DJ, Wilding JPH. Impact of bariatric surgery on physical functioning in obese adults. Obes Rev. 2015;16(3):248–58.PubMedCrossRefGoogle Scholar
  354. 354.
    Maniscalco M, Zedda A, Giardiello C, et al. Effect of bariatric surgery on the six-minute walk test in severe uncomplicated obesity. Obes Surg. 2006;16(7):836–41.PubMedCrossRefGoogle Scholar
  355. 355.
    Tompkins J, Bosch PR, Chenowith R, et al. Changes in functional walking distance and health-related quality of life after gastric bypass surgery. Phys Ther. 2008;88(8):928–35.PubMedCrossRefGoogle Scholar
  356. 356.
    de Souza SA, Faintuch J, Fabris SM, et al. Six-minute walk test: functional capacity of severely obese before and after bariatric surgery. Surg Obes Relat Dis. 2009;5(5):540–3.PubMedCrossRefGoogle Scholar
  357. 357.
    Josbeno DA, Jakicic JM, Hergenroeder A, et al. Physical activity and physical function changes in obese individuals after gastric bypass surgery. Surg Obes Relat Dis. 2010;6(4):361–6.PubMedCrossRefGoogle Scholar
  358. 358.
    De Souza SA, Faintuch J, Sant’anna AF. Effect of weight loss on aerobic capacity in patients with severe obesity before and after bariatric surgery. Obes Surg. 2010;20(7):871–5.PubMedCrossRefGoogle Scholar
  359. 359.
    Lyytinen T, Liikavainio T, Pääkkönen M, et al. Physical function and properties of quadriceps femoris muscle after bariatric surgery and subsequent weight loss. J Musculoskelet Neuronal Interact. 2013;13(3):329–38.PubMedGoogle Scholar
  360. 360.
    Vargas CB, Picolli F, Dani C, et al. Functioning of obese individuals in pre- and postoperative periods of bariatric surgery. Obes Surg. 2013;23(10):1590–5.PubMedCrossRefGoogle Scholar
  361. 361.
    Iossi MF, Konstantakos EK, Teel 2nd DD, et al. Musculoskeletal function following bariatric surgery. Obesity (Silver Spring). 2013;21(6):1104–10.CrossRefGoogle Scholar
  362. 362.
    Miller GD, Nicklas BJ, You T, et al. Physical function improvements after laparoscopic Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2009;5(5):530–7.PubMedCrossRefGoogle Scholar
  363. 363.
    Kanoupakis E, Michaloudis D, Fraidakis O, et al. Left ventricular function and cardiopulmonary performance following surgical treatment of morbid obesity. Obes Surg. 2001;11(5):552–8.PubMedCrossRefGoogle Scholar
  364. 364.
    Serés L, Lopez-Ayerbe J, Coll R, et al. Increased exercise capacity after surgically induced weight loss in morbid obesity. Obesity (Silver Spring). 2006;14(2):273–9.CrossRefGoogle Scholar
  365. 365.
    Valezi AC, Machado VH. Morphofunctional evaluation of the heart of obese patients before and after bariatric surgery. Obes Surg. 2011;21(11):1693–7.PubMedCrossRefGoogle Scholar
  366. 366.
    Wasmund SL, Owan T, Yanowitz FG, et al. Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study. Heart Rhythm. 2011;8(1):84–90.PubMedCrossRefGoogle Scholar
  367. 367.
    Wilms B, Ernst B, Thurnheer M, et al. Differential changes in exercise performance after massive weight loss induced by bariatric surgery. Obes Surg. 2013;23(3):365–71.PubMedCrossRefGoogle Scholar
  368. 368.
    Castello V, Simões RP, Bassi D, et al. Impact of aerobic exercise training on heart rate variability and functional capacity in obese women after gastric bypass surgery. Obes Surg. 2011;21(11):1739–49.PubMedCrossRefGoogle Scholar
  369. 369.
    Stegen S, Derave W, Calders P, et al. Physical fitness in morbidly obese patients: effect of gastric bypass surgery and exercise training. Obes Surg. 2011;21(1):61–70.PubMedCrossRefGoogle Scholar
  370. 370.
    Terranova L, Busetto L, Vestri A, et al. Bariatric surgery: cost-effectiveness and budget impact. Obes Surg. 2012;22(4):646–53.PubMedCrossRefGoogle Scholar
  371. 371.
    Hernæs UJ, Andersen JR, Norheim OF, et al. Work participation among the morbidly obese seeking bariatric surgery: an exploratory study from Norway. Obes Surg. 2015;25(2):271–8.PubMedCrossRefGoogle Scholar
  372. 372.
    Sjöström L, Larsson B, Backman L, et al. Swedish Obese Subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord. 1992;16(6):465–79.PubMedGoogle Scholar
  373. 373.
    Narbro K, Agren G, Jonsson E, et al. Sick leave and disability pension before and after treatment for obesity: a report from the Swedish Obese Subjects (SOS) study. Int J Obes Relat Metab Disord. 1999;23(6):619–24.PubMedCrossRefGoogle Scholar
  374. 374.
    Gripeteg L, Lindroos AK, Peltonen M, et al. Effects of bariatric surgery on disability pension in Swedish obese subjects. Int J Obes (Lond). 2012;36(3):356–62.CrossRefGoogle Scholar
  375. 375.
    Kolotkin RL, Meter K, Williams GR. Quality of life and obesity. Obes Rev. 2001;2(4):219–29.PubMedCrossRefGoogle Scholar
  376. 376.
    Larsson U, Karlsson J, Sullivan M. Impact of overweight and obesity on health-related quality of life—a Swedish population study. Int J Obes Relat Metab Disord. 2002;26(3):417–24.PubMedCrossRefGoogle Scholar
  377. 377.
    Doll HA, Petersen SE, Stewart-Brown SL. Obesity and physical and emotional well-being: associations between body mass index, chronic illness, and the physical and mental components of the SF-36 questionnaire. Obes Res. 2000;8(2):160–70.PubMedCrossRefGoogle Scholar
  378. 378.
    Kolotkin RL, Crosby RD, Williams GR, et al. The relationship between health-related quality of life and weight loss. Obes Res. 2001;9(9):564–71.PubMedCrossRefGoogle Scholar
  379. 379.
    Karlsson J, Taft C, Sjöström L, et al. Psychosocial functioning in the obese before and after weight reduction: construct validity and responsiveness of the Obesity-related Problems scale. Int J Obes Relat Metab Disord. 2003;27(5):617–30.PubMedCrossRefGoogle Scholar
  380. 380.
    Karlsson J, Taft C, Rydén A, et al. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes (Lond). 2007;31(8):1248–61.CrossRefGoogle Scholar
  381. 381.
    Magallares A, Schomerus G. Mental and physical health-related quality of life in obese patients before and after bariatric surgery: a meta-analysis. Psychol Health Med. 2015;20(2):165–76.PubMedCrossRefGoogle Scholar
  382. 382.
    Batsis JA, Lopez-Jimenez F, Collazo-Clavell ML, et al. Quality of life after bariatric surgery: a population-based cohort study. Am J Med. 2009;122(11):1055.e1–1055.e10.CrossRefGoogle Scholar
  383. 383.
    Suter M, Donadini A, Romy S, et al. Laparoscopic Roux-en-Y gastric bypass: significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg. 2011;254(2):267–73.PubMedCrossRefGoogle Scholar
  384. 384.
    Burgmer R, Legenbauer T, Müller A, et al. Psychological outcome 4 years after restrictive bariatric surgery. Obes Surg. 2014;24(10):1670–8.Google Scholar
  385. 385.
    Black JA, White B, Viner RM, et al. Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis. Obes Rev. 2013;14(8):634–44.PubMedCrossRefGoogle Scholar
  386. 386.
    Kakoulidis TP, Karringer A, Gloaguen T, et al. Initial results with sleeve gastrectomy for patients with class I obesity (BMI 30-35 kg/m2). Surg Obes Relat Dis. 2009;5(4):425–8.PubMedCrossRefGoogle Scholar
  387. 387.
    O’Brien PE, Sawyer SM, Laurie C, et al. Laparoscopic adjustable gastric banding in severely obese adolescents; a randomized trial. JAMA. 2010;303(6):519–26.PubMedCrossRefGoogle Scholar
  388. 388.
    Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641.PubMedGoogle Scholar
  389. 389.
    Faulconbridge LF, Wadden TA, Thomas JG, et al. Changes in depression and quality of life in obese individuals with binge eating disorder: bariatric surgery versus lifestyle modification. Surg Obes Relat Dis. 2013;9:790–6.PubMedCrossRefGoogle Scholar
  390. 390.
    Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.PubMedPubMedCentralCrossRefGoogle Scholar
  391. 391.
    Kolotkin RL, Davidson LE, Crosby RD, et al. Six-year changes in health-related quality of life in gastric bypass patients versus obese comparison groups. Surg Obes Relat Dis. 2012;8(5):625–33.PubMedPubMedCentralCrossRefGoogle Scholar
  392. 392.
    Nguyen NT, Slone JA, Nguyen XM, et al. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg. 2009;250(4):631–41.PubMedGoogle Scholar
  393. 393.
    Søvik TT, Aasheim ET, Taha O, et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial. Ann Intern Med. 2011;155(5):281–91.PubMedCrossRefGoogle Scholar
  394. 394.
    Strain GW, Kolotkin RL, Dakin GF, et al. The effects of weight loss after bariatric surgery on health-related quality of life and depression. Nutr Diabetes. 2014;4:e132.PubMedPubMedCentralCrossRefGoogle Scholar
  395. 395.
    Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics. 2004;114(1):217–23.PubMedCrossRefGoogle Scholar
  396. 396.
    Freedman DS, Mei Z, Srinivasan SR, et al. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr. 2007;150(1):12–7. e2.PubMedCrossRefGoogle Scholar
  397. 397.
    Pratt JS, Lenders CM, Dionne EA, et al. Best practice updates for pediatric/adolescent weight loss surgery. Obesity (Silver Spring). 2009;17(5):901–10.CrossRefGoogle Scholar
  398. 398.
    Fried M, Hainer V, Basdevant A, et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes (Lond). 2007;31(4):569–77.Google Scholar
  399. 399.
    Treadwell JR, Sun F, Schoelles K. Systematic review and meta-analysis of bariatric surgery for pediatric obesity. Ann Surg. 2008;248(5):763–76.PubMedCrossRefGoogle Scholar
  400. 400.
    Michalsky M, Reichard K, Inge T, et al. American Society for Metabolic and Bariatric Surgery. ASMBS pediatric committee best practice guidelines. Surg Obes Relat Dis. 2012;8(1):1–7.PubMedCrossRefGoogle Scholar
  401. 401.
    Società Italiana di Chirurgia dell’Obesità e delle malattie metaboliche (S.I.C.OB.). Linee guida e stato dell’arte della chirurgia bariatrica e metabolica in Italia. Napoli: EdiSES; 2008.Google Scholar
  402. 402.
    Sugerman HJ, DeMaria EJ, Kellum JM, et al. Effects of bariatric surgery in older patients. Ann Surg. 2004;240(2):243–7.PubMedPubMedCentralCrossRefGoogle Scholar
  403. 403.
    Quebbemann B, Engstrom D, Siegfried T, et al. Bariatric surgery in patients older than 65 years is safe and effective. Surg Obes Relat Dis. 2005;1(4):389–92.Google Scholar
  404. 404.
    Hazzan D, Chin EH, Steinhagen E, et al. Laparoscopic bariatric surgery can be safe for treatment of morbid obesity in patients older than 60 years. Surg Obes Relat Dis. 2006;2(6):613–6.Google Scholar
  405. 405.
    Taylor CJ, Layani L. Laparoscopic adjustable gastric banding in patients > or =60 years old: is it worthwhile? Obes Surg. 2006;16(12):1579–83.Google Scholar
  406. 406.
    Dunkle-Blatter SE, St Jean MR, Whitehead C, et al. Outcomes among elderly bariatric patients at a high-volume center. Surg Obes Relat Dis. 2007;3(2):163–9.PubMedCrossRefGoogle Scholar
  407. 407.
    Busetto L, Angrisani L, Basso N, et al. Safety and efficacy of laparoscopic adjustable gastric banding in the elderly. Obesity (Silver Spring). 2008;16(2):334–8.CrossRefGoogle Scholar
  408. 408.
    Villareal DT, Apovian CM, Kushner RF, et al. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, the Obesity Society. Am J Clin Nutr. 2005;82(5):923–34.PubMedGoogle Scholar
  409. 409.
    InterAct Consortium, Langenberg C, Sharp SJ, et al. Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med. 2012;9(6):e1001230.CrossRefGoogle Scholar
  410. 410.
    Thomas EL, Parkinson JR, Frost GS, et al. The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring). 2012;20(1):76–87.CrossRefGoogle Scholar
  411. 411.
    Klöting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab. 2010;299(3):E506–15.PubMedCrossRefGoogle Scholar
  412. 412.
    Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168(15):1609–16.PubMedCrossRefGoogle Scholar
  413. 413.
    Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350(25):2549–57.PubMedCrossRefGoogle Scholar
  414. 414.
    Thorne A, Lonnqvist F, Apelman J, et al. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord. 2002;26(2):193–9.PubMedCrossRefGoogle Scholar
  415. 415.
    Fabbrini E, Tamboli RA, Magkos F, et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology. 2010;139(2):448–55.PubMedPubMedCentralCrossRefGoogle Scholar
  416. 416.
    Vilarrasa N, de Gordejuela AG, Gómez-Vaquero C, et al. Effect of bariatric surgery on bone mineral density: comparison of gastric bypass and sleeve gastrectomy. Obes Surg. 2013;23(12):2086–91.PubMedCrossRefGoogle Scholar
  417. 417.
    Wucher H, Ciangura C, Poitou C, et al. Effects of weight loss on bone status after bariatric surgery: association between adipokines and bone markers. Obes Surg. 2008;18(1):58–65.PubMedCrossRefGoogle Scholar
  418. 418.
    Nakamura KM, Haglind EG, Clowes JA, et al. Fracture risk following bariatric surgery: a population-based study. Osteoporos Int. 2014;25(1):151–8.PubMedCrossRefGoogle Scholar
  419. 419.
    Lalmohamed A, de Vries F, Bazelier MT, et al. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ. 2012;345:e5085.PubMedPubMedCentralCrossRefGoogle Scholar
  420. 420.
    Berarducci A, Haines K, Murr MM. Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbid obesity. Appl Nurs Res. 2009;22(1):35–41.PubMedCrossRefGoogle Scholar
  421. 421.
    Ahlin S, Peltonen M, Anveden Ĺ, Jacobson P, Sjöholm K, Svensson PA, et al. Bariatric surgery increases the risk of osteoporosis and fractures in women in the Swedish Obese subjects study. Obes Facts 2015;8(suppl 1): T8:OS3.3Google Scholar
  422. 422.
    Yu EW, Bouxsein ML, Roy AE, et al. Bone loss after bariatric surgery: discordant results between DXA and QCT bone density. J Bone Miner Res. 2014;29(3):542–50.PubMedPubMedCentralCrossRefGoogle Scholar
  423. 423.
    Bosy-Westphal A, Müller MJ. Identification of skeletal muscle mass depletion across age and BMI groups in health and disease—there is need for a unified definition. Int J Obes (Lond). 2015;39(3):379–86.CrossRefGoogle Scholar
  424. 424.
    Tamboli RA, Hossain HA, Marks PA, et al. Body composition and energy metabolism following Roux-en-Y gastric bypass surgery. Obesity (Silver Spring). 2010;18(9):1718–24.CrossRefGoogle Scholar
  425. 425.
    Carey DG, Pliego GJ, Raymond RL. Body composition and metabolic changes following bariatric surgery: effects on fat mass, lean mass and basal metabolic rate: six months to one-year follow-up. Obes Surg. 2006;16(12):1602–8.PubMedCrossRefGoogle Scholar
  426. 426.
    Pouwels S, Wit M, Teijink JA, et al. Aspects of exercise before or after bariatric surgery: a systematic review. Obes Facts. 2015;8(2):132–46.PubMedCrossRefGoogle Scholar
  427. 427.
    Herman KM, Carver TE, Christou NV, et al. Physical activity and sitting time in bariatric surgery patients 1–16 years post-surgery. Clin Obes. 2014;4(5):267–76.Google Scholar
  428. 428.
    Chaston TB, Dixon JB, O’Brien PE. Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes (Lond). 2007;31(5):743–50.Google Scholar
  429. 429.
    Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 Kg/m2: an integrative review of early studies. Obes Surg. 2010;20(6):776–90.Google Scholar
  430. 430.
    Scopinaro N, Adami GF, Papadia FS, et al. The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30–35 kg/m2) and simple overweight (BMI 25–30 kg/m2): a prospective controlled study. Obes Surg. 2011;21(7):880–8.Google Scholar
  431. 431.
    2004 ASBS Consensus Conference on Surgery for Severe Obesity. Surg Obes Relat Dis. 2005;1(3):297–381.Google Scholar
  432. 432.
    Sauerland S, Angrisani L, Belachew M, et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2005;19(2):200–21.PubMedCrossRefGoogle Scholar
  433. 433.
    Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251(3):399–405.PubMedCrossRefGoogle Scholar
  434. 434.
    Maglione MA, Gibbons MM, Livhits M, Ewing B, Hu J, Ruelaz Maher A, et al. Bariatric surgery and nonsurgical therapy in adults with metabolic conditions and a body mass index of 30.0 to 34.9 kg/m2. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013. Report No.: 12(13)-EHC139-EF.Google Scholar
  435. 435.
    Parikh M, Issa R, Vieira D, et al. Role of bariatric surgery as treatment for type 2 diabetes in patients who do not meet current NIH criteria: a systematic review and meta-analysis. J Am Coll Surg. 2013;217(3):527–32.PubMedCrossRefGoogle Scholar
  436. 436.
    Demaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the bariatric outcomes longitudinal database. Ann Surg. 2010;252(3):559–66.PubMedGoogle Scholar
  437. 437.
    Angrisani L, Favretti F, Furbetta F, et al. Italian Group for Lap-Band System: results of multicenter study on patients with BMI < or =35 kg/m2. Obes Surg. 2004;14(3):415–8.Google Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Maurizio De Luca
    • 1
    Email author
  • Luigi Angrisani
    • 2
  • Jacques Himpens
    • 3
  • Luca Busetto
    • 4
  • Nicola Scopinaro
    • 5
  • Rudolf Weiner
    • 6
  • Alberto Sartori
    • 1
  • Christine Stier
    • 6
  • Muffazal Lakdawala
    • 7
  • Aparna G. Bhasker
    • 7
  • Henry Buchwald
    • 8
  • John Dixon
    • 9
  • Sonja Chiappetta
    • 6
  • Hans-Christian Kolberg
    • 10
  • Gema Frühbeck
    • 11
  • David B. Sarwer
    • 12
  • Michel Suter
    • 13
  • Emanuele Soricelli
    • 14
  • Mattias Blüher
    • 15
  • Ramon Vilallonga
    • 16
  • Arya Sharma
    • 17
  • Scott Shikora
    • 18
  1. 1.Director Department of SurgeryMontebelluna Treviso HospitalMontebellunaItaly
  2. 2.University Federico II of NaplesNaplesItaly
  3. 3.The European School of Laparoscopic SurgeryBrusselsBelgium
  4. 4.University of PaduaPaduaItaly
  5. 5.Univerity of GenoaGenoaItaly
  6. 6.Sana Klinikum OffenbachOffenbachGermany
  7. 7.CODS, Saifee, HospitalMumbayIndia
  8. 8.Univerity of MinnesotaMinneapolisUSA
  9. 9.Baker IDI Heart and Diabetes InstituteMelbourneAustralia
  10. 10.Gynecologyc and Obstretics ClinicMarienhospitalBottropGermany
  11. 11.Clinica Universitaria de NavarraPamplonaSpain
  12. 12.Temple UniversityPhiladelphiaUSA
  13. 13.University Hospital of LausanneLausanneSwitzerland
  14. 14.Universita degli Studi di Roma La SapienzaRomeItaly
  15. 15.Department of MedicineUniversity of LeipzigLeipzigGermany
  16. 16.Universidad Autonoma de BarcelonaBarcelonaSpain
  17. 17.Obesity Research ManagementUniversity of AlbertaEdmontonCanada
  18. 18.Brigham and Women’s HospitalBostonUSA

Personalised recommendations